The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual receptor agonist to conduct a head-to-head comparison with semaglutide in diabetes treatment SAN… Continue reading Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
Tag: Financial Results
Rosen Law Firm Encourages Designer Brands Inc. Investors to Inquire About Securities Class Action Investigation – DBI
NEW YORK, Oct. 26, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Designer Brands Inc. (NYSE: DBI) resulting from allegations that Designer Brands may have issued materially misleading business information to the investing public. So What: If you purchased Designer… Continue reading Rosen Law Firm Encourages Designer Brands Inc. Investors to Inquire About Securities Class Action Investigation – DBI
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity expects to separate its early-stage precision cardiology programs into a new company (“SpinCo”) Closing expected in 1H2026 subject to completion of the separation of SpinCo from Avidity and other customary closing conditions SAN DIEGO,… Continue reading Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
FTNT Investors Have Opportunity to Lead Fortinet, Inc. Securities Fraud Lawsuit
NEW YORK, Oct. 26, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fortinet, Inc. (NASDAQ: FTNT) between November 8, 2024 and August 6, 2025, both dates inclusive (the “Class Period”), of the important November 21, 2025 lead plaintiff deadline. So what: If you purchased Fortinet… Continue reading FTNT Investors Have Opportunity to Lead Fortinet, Inc. Securities Fraud Lawsuit
Is Continental Still a Bargain After 49.9% Surge and Electric Mobility Partnership?
Wondering if now is the right moment to make a move with Continental stock? You are not alone. Continental has been catching investors’ attention with a recent surge, jumping 13.1% over the last month and posting an impressive 49.9% gain for the past year. That is more than just a hot streak, as it hints… Continue reading Is Continental Still a Bargain After 49.9% Surge and Electric Mobility Partnership?
Autoliv (ALV): Exploring Valuation After 25% Year-to-Date Share Price Gain
Autoliv (ALV) shares have held steady recently, even as investors digest ongoing shifts in the global auto sector. With returns up 25% year to date, the company’s performance is drawing attention among those tracking automotive suppliers. See our latest analysis for Autoliv. After rallying sharply this year, Autoliv’s 25.3% year-to-date share price return has stood… Continue reading Autoliv (ALV): Exploring Valuation After 25% Year-to-Date Share Price Gain
Goodyear (GT): Exploring Valuation Potential After Recent Share Price Fluctuations
Goodyear Tire & Rubber (GT) shares have seen modest movement in recent trading, catching the attention of investors tracking value and performance. The company’s stock has shifted over the past month, which has sparked curiosity about its long-term prospects. See our latest analysis for Goodyear Tire & Rubber. The past year has seen Goodyear Tire… Continue reading Goodyear (GT): Exploring Valuation Potential After Recent Share Price Fluctuations
Nio Stock Faces a New Hurdle. Is It a Buy on the Dip?
Nio shares have doubled since July, but there’s a new twist that could impact the stock. Nio (NIO +0.14%) stock has been on the move in recent months. Shares of the Chinese electric vehicle (EV) maker have doubled just since July. That’s mainly because vehicle deliveries have set new monthly records in August and September.… Continue reading Nio Stock Faces a New Hurdle. Is It a Buy on the Dip?
TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Dow Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – DOW
SAN DIEGO, Oct. 26, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, all dates inclusive (the “Class Period”), have until this upcoming Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow… Continue reading TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Dow Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – DOW
Meta Tells Employees Their Jobs Are Being Automated
Illustration by Tag Hartman-Simkins / Futurism. Source: Gilbert Flores / Variety via Getty Images Meta’s CEO Mark Zuckerberg is well known for running some pretty high-stakes experiments with his companies. His latest, it seems, is to gut the tech giant of its human workers and replace them with AI. In an internal memo viewed by… Continue reading Meta Tells Employees Their Jobs Are Being Automated